Brief: AB Science To Present Results From Masitinib Study Ab07015 At American Thoracic Society Symposium
13/10/2020 17:26
Oct 13 (Reuters) - AB SCIENCE SA ABS.PA :
* ANNOUNCES THAT RESULTS FROM MASITINIB STUDY AB07015 IN
SEVERE
ASTHMA HAVE BEEN SELECTED FOR PRESENTATION AT AN ATS SYMPOSIUM
HELD ON 16TH OCTOBER, 2020
Source text for Eikon: ID:nGNE5495gH
Further company coverage: ABS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on AB Science SA
See all newsBrief: AB Science Temporarily Halts Europe Clinical Trials Ahead Of Strategic Reorganization
Brief: AB Science Says FDA Granted Status Of Minor Use In Major Species For Masivet
Brief: AB Science Says Co Received Japanese Patent Protection To Use Masitinib In Progressive MS Until 2041
Brief: AB Science Phase 1 AML Study Of AB8939 Shows 100% Partial Response Rate
Brief: AB Science Receives Notice Of Allowance For European Patent Covering Masitinib Until 2040 In Treatment Of Sickle Cell Disease